Industry Bulletins | August 3, 2022
India-Based Fitterfly, A Digital Health Therapeutics Company Focused On Diabetes Management, Raised $12 Million
Fitterfly, an India-based health tech start-up specializing in digital therapeutics (DTx) raised $12 million in a Series A funding round. Fitterfly will use the funds to enhance its technology stack and branding, and improve the reach of its diabetes management DTx program, Diabefly.
The round was led by Amazon Smbhav Venture Fund and Fireside Ventures. 9 Unicorns, Venture Catalysts, Nihar Parikh of 4point0 Health Ventures, and Sriram Natarajan of Molbio also participated in the round.
The Fitterfly Dtx programs offer personalized guidance and motivation on nutrition, exercise, stress, weight, and sleep management. The programs provide a 360-degree . . .